Literature DB >> 10606438

Potential interactions of zinc in the neuroendocrine-endocrine disturbances of diabetes mellitus type 2.

D L Tallman1, C G Taylor.   

Abstract

An accumulation of evidence implicates leptin, insulin, glucocorticoids, proopiomelanocortin (POMC), and neuropeptide Y (NPY) interactions as being integral to metabolic control associated with neuroendocrine-endocrine functioning. Dysfunction of neuroendocrine-endocrine interactions contributes to the metabolic disturbances of diabetes mellitus type 2 (DM-2). Since Zn has a direct impact on the healthy functioning of hormonal and neuropeptide balance, it is possible that altered Zn status and metabolism in DM-2 are involved in some of the metabolic dysfunctions of DM-2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606438

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  5 in total

1.  Zinc transporter expression in zebrafish (Danio rerio) during development.

Authors:  Emily Ho; Stephanie Dukovcic; Brad Hobson; Carmen P Wong; Galen Miller; Karin Hardin; Maret G Traber; Robert L Tanguay
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-05-11       Impact factor: 3.228

2.  Is serum zinc associated with pancreatic beta cell function and insulin sensitivity in pre-diabetic and normal individuals? Findings from the Hunter Community Study.

Authors:  Khanrin P Vashum; Mark McEvoy; Abul Hasnat Milton; Md Rafiqul Islam; Stephen Hancock; John Attia
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

Review 3.  Zinc in Pancreatic Islet Biology, Insulin Sensitivity, and Diabetes.

Authors:  Wolfgang Maret
Journal:  Prev Nutr Food Sci       Date:  2017-03-31

Review 4.  Crosstalk between zinc and free fatty acids in plasma.

Authors:  James P C Coverdale; Siavash Khazaipoul; Swati Arya; Alan J Stewart; Claudia A Blindauer
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-09-25       Impact factor: 4.698

5.  Zinc transporter 8 (ZnT8) expression is reduced by ischemic insults: a potential therapeutic target to prevent ischemic retinopathy.

Authors:  Michael Deniro; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.